• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善临床试验报告和方案中的结果报告:临床试验计划终点报告工具(InsPECT)的研究方案。

Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).

作者信息

Butcher Nancy J, Monsour Andrea, Mew Emma J, Szatmari Peter, Pierro Agostino, Kelly Lauren E, Farid-Kapadia Mufiza, Chee-A-Tow Alyssandra, Saeed Leena, Monga Suneeta, Ungar Wendy, Terwee Caroline B, Vohra Sunita, Fergusson Dean, Askie Lisa M, Williamson Paula R, Chan An-Wen, Moher David, Offringa Martin

机构信息

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada.

Department of Psychiatry, The Hospital for Sick Children, Toronto, Canada.

出版信息

Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.

DOI:10.1186/s13063-019-3248-0
PMID:30841935
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6404348/
Abstract

BACKGROUND

Inadequate and poor quality outcome reporting in clinical trials is a well-documented problem that impedes the ability of researchers to evaluate, replicate, synthesize, and build upon study findings and impacts evidence-based decision-making by patients, clinicians, and policy-makers. To facilitate harmonized and transparent reporting of outcomes in trial protocols and published reports, the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT) is being developed. The final product will provide unique InsPECT extensions to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT (Consolidated Standards of Reporting Trials) reporting guidelines.

METHODS

The InsPECT SPIRIT and CONSORT extensions will be developed in accordance with the methodological framework created by the EQUATOR (Enhancing the Quality and Transparency of Health Research Quality) Network for reporting guideline development. Development will consist of (1) the creation of an initial list of candidate outcome reporting items synthesized from expert consultations and a scoping review of existing guidance for reporting outcomes in trial protocols and reports; (2) a three-round international Delphi study to identify additional candidate items and assess candidate item importance on a 9-point Likert scale, completed by stakeholders such as trial report and protocol authors, systematic review authors, biostatisticians and epidemiologists, reporting guideline developers, clinicians, journal editors, and research ethics board representatives; and (3) an in-person expert consensus meeting to finalize the set of essential outcome reporting items for trial protocols and reports, respectively. The consensus meeting discussions will be independently facilitated and informed by the empirical evidence identified in the primary literature and through the opinions (aggregate rankings and comments) collected via the Delphi study. An integrated knowledge translation approach will be used throughout InsPECT development to facilitate implementation and dissemination, in addition to standard post-development activities.

DISCUSSION

InsPECT will provide evidence-informed and consensus-based standards focused on outcome reporting in clinical trials that can be applied across diverse disease areas, study populations, and outcomes. InsPECT will support the standardization of trial outcome reporting, which will maximize trial usability, reduce bias, foster trial replication, improve trial design and execution, and ultimately reduce research waste and help improve patient outcomes.

摘要

背景

临床试验中结果报告不充分且质量不佳是一个有充分文献记载的问题,这阻碍了研究人员评估、复制、综合和基于研究结果进行拓展的能力,并影响患者、临床医生和政策制定者基于证据的决策。为促进在试验方案和已发表报告中对结果进行统一和透明的报告,正在开发临床试验计划终点报告工具(InsPECT)。最终产品将为SPIRIT(标准方案项目:干预性试验建议)和CONSORT(报告试验的统一标准)报告指南提供独特的InsPECT扩展。

方法

InsPECT对SPIRIT和CONSORT的扩展将根据EQUATOR(提高卫生研究质量和透明度)网络为报告指南制定创建的方法框架来开发。开发将包括:(1)创建一份候选结果报告项目的初始清单,该清单综合了专家咨询意见以及对试验方案和报告中结果报告现有指南的范围审查;(2)三轮国际德尔菲研究,以识别其他候选项目,并由试验报告和方案作者、系统评价作者、生物统计学家和流行病学家、报告指南开发者、临床医生、期刊编辑和研究伦理委员会代表等利益相关者对候选项目的重要性进行9分制李克特量表评估;(3)一次面对面的专家共识会议,分别确定试验方案和报告的基本结果报告项目集。共识会议的讨论将由独立人员主持,并以在主要文献中确定的实证证据以及通过德尔菲研究收集的意见(综合排名和评论)为依据。除了标准的开发后活动外,在InsPECT开发过程中将采用综合知识转化方法,以促进实施和传播。

讨论

InsPECT将提供基于证据且经共识达成的标准,重点关注临床试验中的结果报告,这些标准可应用于不同的疾病领域、研究人群和结果。InsPECT将支持试验结果报告的标准化,这将最大限度地提高试验的可用性、减少偏差、促进试验复制、改善试验设计和执行,并最终减少研究浪费并有助于改善患者结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3832/6404348/defe990b5469/13063_2019_3248_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3832/6404348/defe990b5469/13063_2019_3248_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3832/6404348/defe990b5469/13063_2019_3248_Fig1_HTML.jpg

相似文献

1
Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).改善临床试验报告和方案中的结果报告:临床试验计划终点报告工具(InsPECT)的研究方案。
Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.
2
Guidance for reporting outcomes in clinical trials: scoping review protocol.临床试验结局报告指南:范围综述方案。
BMJ Open. 2019 Feb 19;9(2):e023001. doi: 10.1136/bmjopen-2018-023001.
3
Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.临床试验方案和报告结局报告建议:范围综述。
Trials. 2020 Jul 8;21(1):620. doi: 10.1186/s13063-020-04440-w.
4
Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.儿科和儿童健康临床试验方案和报告报告指南:SPIRIT-Children 和 CONSORT-Children 的研究方案。
Trials. 2024 Jan 30;25(1):96. doi: 10.1186/s13063-024-07948-7.
5
Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.试验方案中报告结果的指南:SPIRIT-结果2022扩展版
JAMA. 2022 Dec 20;328(23):2345-2356. doi: 10.1001/jama.2022.21243.
6
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.试验报告中结果报告指南:CONSORT-结果2022扩展版
JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022.
7
Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.儿科临床试验方案和报告中报告项目的建议与证据:两项系统评价
Trials. 2015 Sep 18;16:417. doi: 10.1186/s13063-015-0954-0.
8
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.患者报告结局纳入临床试验方案指南:SPIRIT-PRO 扩展
JAMA. 2018 Feb 6;319(5):483-494. doi: 10.1001/jama.2017.21903.
9
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.早期阶段剂量发现临床试验的 SPIRIT 和 CONSORT 扩展:DEFINE(剂量发现扩展)研究方案。
BMJ Open. 2023 Mar 29;13(3):e068173. doi: 10.1136/bmjopen-2022-068173.
10
COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).COS-STAR:核心结局集开发研究的报告指南(方案)
Trials. 2015 Aug 22;16:373. doi: 10.1186/s13063-015-0913-9.

引用本文的文献

1
Development of START-EDI guidelines for reporting equality, diversity and inclusion in research: a study protocol.制定START-EDI研究平等、多样性和包容性报告指南:一项研究方案
BMJ Open. 2025 Jul 16;15(7):e095778. doi: 10.1136/bmjopen-2024-095778.
2
Assessing the completeness of patient-reported outcomes reporting in congestive heart failure clinical trials.评估充血性心力衰竭临床试验中患者报告结局报告的完整性。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241303724. doi: 10.1177/17539447241303724.
3
The OHStat guidelines for reporting observational studies and clinical trials in oral health research: manuscript checklist.

本文引用的文献

1
Guidance for reporting outcomes in clinical trials: scoping review protocol.临床试验结局报告指南:范围综述方案。
BMJ Open. 2019 Feb 19;9(2):e023001. doi: 10.1136/bmjopen-2018-023001.
2
Appendectomy versus non-operative treatment for acute uncomplicated appendicitis in children: study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.儿童急性单纯性阑尾炎的阑尾切除术与非手术治疗:一项多中心、开放标签、非劣效性随机对照试验的研究方案
BMJ Paediatr Open. 2017 May 18;1(1). doi: 10.1136/bmjpo-2017-000028. eCollection 2017.
3
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
OHStat 指导原则:口腔健康研究中报告观察性研究和临床试验的规范:手稿清单。
Angle Orthod. 2024 Sep 1;94(5):479-487. doi: 10.2319/OHStat_Guidelines.1.
4
Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?多利益相关方德尔菲调查中的样本量:结果的可重复性在什么最小样本量时会趋于稳定?
J Clin Epidemiol. 2024 Oct;174:111485. doi: 10.1016/j.jclinepi.2024.111485. Epub 2024 Jul 26.
5
The OHStat Guidelines for Reporting Observational Studies and Clinical Trials in Oral Health Research: Manuscript Checklist.口腔健康研究中观察性研究和临床试验报告的 OHStat 指南:手稿清单。
J Dent Res. 2024 Oct;103(11):1076-1082. doi: 10.1177/00220345241247028. Epub 2024 Jul 12.
6
A methodological quality review of citations of randomized controlled trials of diabetes type2 in leading clinical practice guidelines and systematic reviews.对主要临床实践指南和系统评价中2型糖尿病随机对照试验引文的方法学质量回顾。
J Diabetes Metab Disord. 2023 Oct 19;23(1):101-114. doi: 10.1007/s40200-023-01328-9. eCollection 2024 Jun.
7
Primary outcome reporting in clinical trials for older adults with depression.老年抑郁症患者临床试验中的主要结局报告
BJPsych Open. 2024 Mar 7;10(2):e60. doi: 10.1192/bjo.2023.650.
8
Completeness and consistency of primary outcome reporting in COVID-19 publications in the early pandemic phase: a descriptive study.新冠疫情早期阶段 COVID-19 研究出版物中主要结局报告的完整性和一致性:描述性研究。
BMC Med Res Methodol. 2023 Jul 29;23(1):173. doi: 10.1186/s12874-023-01991-9.
9
Surrogate endpoints in trials: a call for better reporting.临床试验中的替代终点:提高报告质量的呼吁。
Trials. 2022 Dec 12;23(1):991. doi: 10.1186/s13063-022-06904-7.
10
Identification of high-risk factors for prehospital delay for patients with stroke using the risk matrix methods.应用风险矩阵方法识别脑卒中患者院前延误的高危因素。
Front Public Health. 2022 Nov 11;10:858926. doi: 10.3389/fpubh.2022.858926. eCollection 2022.
患者报告结局纳入临床试验方案指南:SPIRIT-PRO 扩展
JAMA. 2018 Feb 6;319(5):483-494. doi: 10.1001/jama.2017.21903.
4
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.临床试验中统计分析计划内容的指南。
JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556.
5
Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications.试验注册与方案及出版物中主要结局报告的关联
JAMA. 2017 Nov 7;318(17):1709-1711. doi: 10.1001/jama.2017.13001.
6
The COMET Handbook: version 1.0.《COMET手册:第1.0版》
Trials. 2017 Jun 20;18(Suppl 3):280. doi: 10.1186/s13063-017-1978-4.
7
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.在 Cochrane 综述中纳入的 20920 项随机对照试验中,研究随时间推移而出现的报告质量差和方法学不足的演变:研究中的研究。
BMJ. 2017 Jun 8;357:j2490. doi: 10.1136/bmj.j2490.
8
Poor outcome reporting in medical research; building practice on spoilt grounds.医学研究中不良的结果报告:在有缺陷的基础上开展实践。
Ann Transl Med. 2017 May;5(Suppl 1):S15. doi: 10.21037/atm.2017.03.75.
9
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis.临床试验中的多种结果和分析给解释和研究综合带来了挑战。
J Clin Epidemiol. 2017 Jun;86:39-50. doi: 10.1016/j.jclinepi.2017.05.007. Epub 2017 May 18.
10
Why clinical trial outcomes fail to translate into benefits for patients.为何临床试验结果无法转化为患者的益处。
Trials. 2017 Mar 14;18(1):122. doi: 10.1186/s13063-017-1870-2.